Actively Recruiting

Age: 19Years +
All Genders
NCT06946784

LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea

Led by Yonsei University · Updated on 2025-04-27

360

Participants Needed

1

Research Sites

357 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a prospective, multicenter observational cohort study aimed at establishing a nationwide post-TB lung disease registry in Korea. The study will enroll adult participants either undergoing treatment for pulmonary tuberculosis or with a history of treated TB. Over a five-year follow-up period, the study will assess the long-term health consequences of TB, focusing on respiratory symptoms, radiological changes, pulmonary function, and quality of life.

CONDITIONS

Official Title

LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 19 years or older
  • Diagnosed with pulmonary tuberculosis and either starting or currently undergoing treatment or with a history of treated pulmonary tuberculosis
Not Eligible

You will not qualify if you...

  • Age under 19 years
  • Extrapulmonary tuberculosis without lung involvement
  • Refusal to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Internal Medicine, Yonsei University College of Medicine Division of Pulmonology, Severance Hospital, Yonsei University Health System

Seoul, South Korea

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here